PPV-06

DRUG2 trials

Sponsors

Peptinov, Peptinov SAS

Conditions

Knee osteoarthritisOsteoarthritis, Knee

Phase 2

PPV-06 Vaccine in Inflammatory Knee Osteoarthritis

Not yet recruitingNCT06605963

Peptinov SASOsteoarthritis, Knee

Start: 2025-12-31End: 2028-12-31Target: 204Updated: 2025-08-12

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of PPV-06 Active Immunotherapy in Patients with Inflammatory Knee Osteoarthritis (KOA).

Not yet recruitingCTIS2024-514388-24-00

PeptinovKnee osteoarthritis

Target: 204Updated: 2025-04-07